EA201400202A1 - Применение эстетрола в качестве экстренного контрацептива - Google Patents

Применение эстетрола в качестве экстренного контрацептива

Info

Publication number
EA201400202A1
EA201400202A1 EA201400202A EA201400202A EA201400202A1 EA 201400202 A1 EA201400202 A1 EA 201400202A1 EA 201400202 A EA201400202 A EA 201400202A EA 201400202 A EA201400202 A EA 201400202A EA 201400202 A1 EA201400202 A1 EA 201400202A1
Authority
EA
Eurasian Patent Office
Prior art keywords
emergency
esthetrol
contractive
application
present
Prior art date
Application number
EA201400202A
Other languages
English (en)
Other versions
EA028780B1 (ru
Inventor
Ваут Ваутерс
Герман Ян Теймен Кулинг-Беннинк
Людивин Пёти
Жан-Мишель Фуадар
Original Assignee
Эстетра С.П.Р.Л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эстетра С.П.Р.Л. filed Critical Эстетра С.П.Р.Л.
Publication of EA201400202A1 publication Critical patent/EA201400202A1/ru
Publication of EA028780B1 publication Critical patent/EA028780B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

Настоящее изобретение относится к новому применению тетрагидроксилированных эстрогенов, таких как эстетрол (1,3,5(10)-эстратриен-3,15α,16α,17β-тетрол), а именно к способу экстренной контрацепции. Способ экстренной контрацепции в соответствии с настоящим изобретением включает пероральное введение эстетрола в однократной дозе в пределах 120 ч от полового сношения.
EA201400202A 2011-08-11 2012-08-09 Применение эстетрола в качестве экстренного контрацептива EA028780B1 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161522480P 2011-08-11 2011-08-11
US61/522,480 2011-08-11
EP11177266 2011-08-11
EP11177266.1 2011-08-11
PCT/EP2012/065572 WO2013021025A1 (en) 2011-08-11 2012-08-09 Use of estetrol as emergency contraceptive

Publications (2)

Publication Number Publication Date
EA201400202A1 true EA201400202A1 (ru) 2014-06-30
EA028780B1 EA028780B1 (ru) 2017-12-29

Family

ID=47667911

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201400202A EA028780B1 (ru) 2011-08-11 2012-08-09 Применение эстетрола в качестве экстренного контрацептива

Country Status (19)

Country Link
US (3) US9579329B2 (ru)
EP (1) EP2741824B1 (ru)
AU (2) AU2012293593B2 (ru)
BR (1) BR112014003113A2 (ru)
CA (1) CA2843951C (ru)
CY (1) CY1118996T1 (ru)
DK (1) DK2741824T3 (ru)
EA (1) EA028780B1 (ru)
ES (1) ES2631359T3 (ru)
HK (1) HK1197027A1 (ru)
HR (1) HRP20170797T1 (ru)
HU (1) HUE033590T2 (ru)
LT (1) LT2741824T (ru)
ME (1) ME02723B (ru)
PL (1) PL2741824T3 (ru)
PT (1) PT2741824T (ru)
RS (1) RS55974B1 (ru)
SI (1) SI2741824T1 (ru)
WO (1) WO2013021025A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11053274B2 (en) 2011-06-01 2021-07-06 Estetra S.P.R.L. Process for the production of estetrol intermediates
CA2835979C (en) 2011-06-01 2018-05-01 Estetra S.A. Process for the production of estetrol intermediates
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
PT2741824T (pt) * 2011-08-11 2017-07-06 Estetra Sprl Utilização de estetrol como contracetivo de emergência
TW201613576A (en) 2014-06-26 2016-04-16 Novartis Ag Intermittent dosing of MDM2 inhibitor
DK3310346T3 (da) 2015-06-18 2021-05-25 Estetra Sprl Orodispersibel tablet indeholdende estetrol
PL3310333T3 (pl) 2015-06-18 2020-07-13 Estetra Sprl Ulegająca rozpadowi w jamie ustnej jednostka dawkowana zawierająca składnik estetrolowy
MA44205B1 (fr) * 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
GEP20217308B (en) 2015-06-18 2021-10-25 Estetra Sprl Orodispersible dosage unit containing an estetrol component
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
HU231240B1 (hu) 2019-09-03 2022-04-28 Richter Gedeon Nyrt. Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására
US20230338355A1 (en) * 2020-07-30 2023-10-26 Acer Therapeutics Inc. Nk antagonists for contraception

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2297273A1 (en) * 2000-01-26 2001-07-26 Michael D. Perelgut 3 dimensional imaging of hard structure without the use of ionizing radiation
ES2296943T3 (es) * 2001-05-23 2008-05-01 Pantarhei Bioscience B.V. Sistema de administracion de un medicamento estrogeno tetrahidroxilado destinado a la contracepcion hormonal.
CA2448273C (en) * 2001-05-23 2010-06-29 Christian Franz Holinka Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
HU227198B1 (en) * 2001-11-27 2010-10-28 Richter Gedeon Nyrt Pharmaceutical composition for emergency contraception containing levonorgestrel
SI1562976T1 (sl) * 2002-11-08 2010-08-31 Pantarhei Bioscience Bv Sinteza estetrola preko steroidov, izvedenih iz estrona
JP2004235111A (ja) * 2003-01-31 2004-08-19 Ebara Corp イオン伝導体及びその製造方法
PT2741824T (pt) * 2011-08-11 2017-07-06 Estetra Sprl Utilização de estetrol como contracetivo de emergência
EA032306B1 (ru) * 2013-12-12 2019-05-31 Донеста Байосайенс Б.В. Орально распадающаяся твердая фармацевтическая единица дозирования, содержащая эстетрольный компонент, ее применение и способ получения

Also Published As

Publication number Publication date
HK1197027A1 (en) 2015-01-02
RS55974B1 (sr) 2017-09-29
US20210290636A1 (en) 2021-09-23
DK2741824T3 (en) 2017-07-10
AU2012293593A1 (en) 2014-03-06
BR112014003113A2 (pt) 2017-03-14
US20140200202A1 (en) 2014-07-17
CA2843951C (en) 2019-08-06
CA2843951A1 (en) 2013-02-14
CY1118996T1 (el) 2018-01-10
EA028780B1 (ru) 2017-12-29
PT2741824T (pt) 2017-07-06
US9579329B2 (en) 2017-02-28
EP2741824B1 (en) 2017-05-03
EP2741824A1 (en) 2014-06-18
US20170196886A1 (en) 2017-07-13
AU2012293593A8 (en) 2014-05-29
HRP20170797T1 (hr) 2017-08-11
SI2741824T1 (sl) 2017-06-30
HUE033590T2 (hu) 2017-12-28
AU2017203991A1 (en) 2017-07-06
ME02723B (me) 2017-10-20
PL2741824T3 (pl) 2018-03-30
AU2012293593B2 (en) 2017-03-23
LT2741824T (lt) 2017-06-26
AU2017203991B2 (en) 2019-03-14
WO2013021025A1 (en) 2013-02-14
ES2631359T3 (es) 2017-08-30

Similar Documents

Publication Publication Date Title
EA201400202A1 (ru) Применение эстетрола в качестве экстренного контрацептива
CL2017000830A1 (es) Formulación estable que comprende un azúcar no reductora, un anticuerpo anti-s4b7 y al menos un aminoácido libre; un método para preparar dicha formulación; uso de dicha formulación para tratar una enfermedad inflamatoria del intestino.
DOP2014000085A (es) Derivados de (4-fenilimidazol-2-il)etilamina útiles como moduladores de canal de sodio
EA201490546A1 (ru) Замещенные аннелированные пиримидины и их применение
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
PE20151436A1 (es) Moduladores de receptores nmda de espiro-lactama y sus usos
BR112015020389A2 (pt) compostos carbazol úteis como inibidores de bromodomínio
CR11455A (es) Compuestos nuevos de hidrocarbono ciclico para el tratamiento de enfermedades
EA201291372A1 (ru) Фармацевтическая композиция, содержащая дроспиренон, и набор для предупреждения зачатия
AR084932A1 (es) Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica
MY181159A (en) Sublingual and buccal film compositions
NZ714684A (en) Stable oral solutions for combined api
BR112012013487A2 (pt) Composições de amantadina e métodos de uso
UA113962C2 (xx) Фармацевтична композиція, яка містить апоморфін як активний інгредієнт
MX2016000294A (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
EA201270573A1 (ru) Гранулированный в расплаве цинакальцет
EA201691299A1 (ru) Применение лахинимода для замедления прогрессирования болезни хантингтона
CL2010001577A1 (es) Uso de nifurtimox para preparar un medicamento util en el tratamiento de enfermedades causadas por giardias.
AR089114A1 (es) PREVENCION DE LOS EFECTOS ADVERSOS CAUSADOS POR LOS ANTICUERPOS BIESPECIFICOS EpCAMxCD3
MX359887B (es) Composicion masticable para administracion oral y proceso para preparar la misma.
NZ622927A (en) Composition comprising scirpusin a and scirpusin b anti-obesity potential thereof
MX2013012038A (es) Combinacion de carotenoide, fitoestrogeno y vitamina c para la humectacion de la piel.
MX2020006075A (es) Composiciones farmaceuticas de bendamustina.
PH12015501110A1 (en) Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception
EA201500155A1 (ru) Фармацевтические композиции, содержащие ипидакрин, и их применение для лечения нарушений потенции и нарушений других форм половой активности